Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

IRS-2 polypeptide for diagnosis of insulin- or immune-related disorders available for licensing

Oct. 25, 1996

European approval recommended for LeukoScan

Oct. 25, 1996

FDA accepts EchoGen filing

Oct. 25, 1996

Techtide P829 in phase III for detecting the spread of melanoma

Oct. 25, 1996

Nymox prepares filings for Alzheimer's diagnostic test

Oct. 25, 1996

Genzyme launches HDL cholesterol test in the U.S.

Oct. 25, 1996

Diagnostic Products expands its array of allergy tests

Oct. 25, 1996

NIH seeks licensees for method for detecting TSEs

Oct. 18, 1996

Palatin receives funds to develop somatostatin analogue as cancer diagnostic

Oct. 18, 1996

Digene-Cytyc alliance focusing on cervical cancer

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...